Method of treating rheumatoid arthritis with low dose type II co

Details Method of treating rheumatoid arthritis with low dose type II co Method of treating rheumatoid arthritis with low dose type II co

1996-07-05

1999-01-05

Criares, Theodore J.

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

Scleroproteins, e.g., fibroin, elastin, silk, etc.

514885, A61K 3817

Patent

active

058564462

ABSTRACT:
A method for suppressing autoimmune response in an afflicted joint in a human. The method involves oral administration of between about 5 and 25 .mu.g per day of type II collagen.

REFERENCES:
patent: 3561444 (1971-02-01), Boucher
patent: 3703173 (1972-11-01), Dixon
patent: 4309404 (1982-01-01), DeNeale et al.
patent: 4309406 (1982-01-01), Guley et al.
patent: 4556552 (1985-12-01), Porter et al.
patent: 4624251 (1986-11-01), Miller
patent: 4635627 (1987-01-01), Gam
patent: 4659696 (1987-04-01), Hirai et al.
patent: 4695459 (1987-09-01), Steinman et al.
patent: 4698332 (1987-10-01), Ogasawara et al.
patent: 4804745 (1989-02-01), Koepff et al.
patent: 4863720 (1989-09-01), Burghart et al.
patent: 4883784 (1989-11-01), Kaneko
patent: 5075112 (1991-12-01), Lane
patent: 5194425 (1993-03-01), Sharma et al.
patent: 5276013 (1994-01-01), Conrad et al.
patent: 5284935 (1994-02-01), Clark et al.
patent: 5399347 (1995-03-01), Trentham et al.
AutoImmune Press Release of May 12, 1997.
Allegretta et al., Science, 247:718, 1990.
Al-Sabbagh et al., Neurology, 42:346, 1992.
Alvord et al., Annals of Neurol., 6:461, 1979.
Alvord et al., Annals of Neurol., 6:469, 1979.
Alvord et al., Annals of Neurol., 6:474,1979.
Alvord et al., Ann. N.Y. Acad. Sci., 122:333, 1965.
Avrilionis et al., J. Neuroimmunol., 35:201, 1991.
Barker et al., Clin. Exp. Immunol., 85:33, 1991.
Belik et al., Vorp. Med. Khim., 24:372, 1978.
Ben-Nun et al., J. Immunol., 129:303, 1982.
Bitar et al., Cell Immunol., 112:364, 1988.
Bitar, Dissertation entitled The Suppressive Effects of Oral Myelin . . . , 1986.
Bradley-Mullen et al., Cell Immunol., 39:289, 1978.
Bradley-Mullen et al., Cell Immunol., 51:408, 1980.
Burns et al., Neurology, 36:92, 1986.
Burns et al., J. Exp. Med., 169:27, 1989.
Campbell et al., Arch. Neurol., 29:10, 1973.
Carnegie et al., Immunology, 19:55, 1970.
Chen et al., Science, 265:1237, 1994.
Cremer et al., J. Immunol., 131:2995, 1983.
DeHeer et al., J. Immunol., 16:1051, 1976.
Eisenbarth, New Eng. J. Med., 314:1360, 1986.
Englert et al., Cell Immunol., 87:357, 1984.
Eylar, Adv. Exp. Med. Bio., 98:259, 1978.
Eylar et al., Nature, 236:74, 1972.
Eylar et al., Neurochem. Res., 4:249, 1979.
Friedman et al., Proc. Nat'l. Acad. Sci., USA, 91:6688, 1994.
Fritz et al., J. Immunol., 134:2328, 1985.
Fritz et al., J. Immunol., 130:191, 1983.
Fritz et al., J. Immunol., 130:1024, 1983.
Gaur et al., Science, 258:1491, 1992.
Gautam et al., J. Immunol., 135:2975, 1985.
Gonsette et al., J. Neurol., 216:27, 1977.
Harrison et al., J. Clin. Invest. 89:1161, 1992.
Hashim et al., Arch. of Biochem. and Biophysics, 156:287, 1973.
Higgins et al., J. Immunol., 140:440, 1988.
Higgins et al., J. Neuroimmunol., 16:77, 1987.
Higgins et al., Annals of Neurol., 20:161, abstract P154, 1986.
Holoshitz et al., J. Immunol., 131:2810, 1983.
Holoshitz et al., Science, 219:56, 1983.
Howell et al., Science, 246:668, 1989.
Janeway, Nature, 341:482, 1989.
Kagnoff, Annals N.Y. Acad. Sci., pp. 248-265, 1982.
Kardys et al., J. Immunol., 127:862, 1981.
Khoury et al., J. Exp. Med., 176:1355, 1992.
Lando et al., Nature, 287:551, 1980.
Lando et al., J. Immunol., 126:1526, 1981.
Lane et al., Sharks Don't Get Cancer, 1992.
Lider et al., J. Immunol., 142:748, 1989.
Lider et al., Ann. N.Y. Acad. Sci., 475:267, 1986.
Martin et al., J. Immunol., 148:1359, 1992.
Martin et al., J. Exp. Med., 173:19, 1991.
Martin et al., J. Immunol., 145:540, 1990.
Mattingly et al., J. Immunol., 125:1044, 1980.
McDermott et al., J. Neurol. Sci., 46:137, 1980.
McKenna et al., Cell Immunol., 81:391, 1983.
McKenna et al., Cell Immunol., 88:251, 1984.
Michael, Immunol. Invest., 18:1049, 1989.
Miller et al., J. Exp. Med., 174:791, 1991.
Miller et al., Proc. Nat'l. Acad. Sci., USA, 89:421, 1992.
Miller, FASEB, 5:2560, 1991.
Miller et al., J. Neuroimmunol., 39:243, 1992.
Miller et al., J. Neuroimmunol., 46:73, 1993.
Miller et al., J. Immunol., 151:7307, 1993.
Mokhtarian et al., Nature, 309:356, 1984.
Mori et al., Diabetologia, 29:244, 1986.
Mowat, Immunol. Today, 8:93, 1987.
Myers et al., J. Exp. Med., 170:1999, 1989.
Myers et al., J. Immunol., 143:3976, 1989.
Nagler-Anderson et al., Proc. Nat'l., Acad. Sci. USA., 83:7443, 1986.
Nagler-Anderson, Dissertation entitled Immunoregulation of an Expermental Model . . . , 1986.
Newman, Aerosols and the Lung, pp. 197-224, 1984.
Ngan et al., J. Immunol., 120:861, 1987.
Nussenblatt et al., J. Immunol., 144:1689, 1990.
Ota et al., Nature, 346:183, 1990.
Pette et al., Proc. Nat'l. Acad. Sci., USA, 87:7968, 1990.
Pettinelli et al., J. Immunol., 129:1209, 1982.
Phadke et al., Arthritis and Rheumatism, 27:797, 1984.
Pinals et al., Arthritis Rheum., 24:1308, 1981.
Raine et al., Lab. Invest., 48:275, 1983.
Rama et al., Connective Tissue Research, 12:111, 1984.
Raziuddin et al., J. Immunol., 128:2073, 1982.
Richman et al., J. Immunol., 121:2429, 1978.
Rothbard, 1st Forum in Virology, pp. 518-527, 1986.
Salk et al., Studies of Myelin Basic Protein . . . , 419-427, 1984.
Santos et al., J. Immunol., 150:115A, 1993.
Schoen et al., J. Immunol., 128:717, 1982.
Schwartz, Ann. Rev. Immunol., 3:237, 1985.
Sewel et al., The Lancet, 341:283, 1993.
Sriram et al., Cell Immunol., 75:378, 1983.
Steinbroker et al,. JAMA, 140:659, 1949.
Strejan et al., Cell Immunol., 84:171, 1984.
Su et al., J. Neuroimmunol., 34:181, 1991.
Swierkosz et al., J. Immunol., 119:1501, 1977.
Thompson et al., Clin. Exp. Immunol., 64:581, 1985.
Titus et al., Int. Arch. Allergy Appl. Immunol., 65:323, 1981.
Traugott et al., J. Neurol. Sci., 56:65, 1982,
Trentham et al., J. Clin. Invest., 66:1109, 1980.
Trentham et al., Science, 261:1727, 1993.
Unanue et al., Science, 236:551, 1987.
Vandenbark et al., Nature, 341:541, 1989.
Weinblatt et al., N. Eng. J. Med., 312:818, 1985.
Weiner et al., Science, 259:1321, 1993.
Weiner et al., Neurology, 39:172, 1989.
Wells, J. Infect. Dis., 9:147, 1911.
Whitacre et al., 6th Int'l. Cong. Immunol., 1986.
Whitacre et al.,, 5th Int'l. Cong. Immunol. 1983.
Whitacre et al., J. Immunol. 147:2155, 1991.
Whitaker, J. Bio. Chem., 250:9106, 1975.
Williams et al., Arthritis Rheum., 31:702, 1988.
Wucherpfenning et al., Science, 248:1016, 1990.
Yoon, Science, 259:1263, 1993.
Zamvil et al., Nature, 324:258, 1986.
Zhang et al., FASEBJ, 4:A3264), 1990.
Zhang et al., Proc. Natl'l. Acad. Sci. USA, 88:10252, 1991.
Zhang et al., J. Immunol., 145:2489, 1990.
Zhang et al., Arthritis Rheum, 33:(abstract No. C10), 1990.
Zhang et al., Arthritis Rheum., 33:(abstract No. C11), 1990.
Zhang et al., FASEBJ., 6A1693, 1992.

Affiliated with

Also associated with

Rating

Method of treating rheumatoid arthritis with low dose type II co does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating rheumatoid arthritis with low dose type II co, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating rheumatoid arthritis with low dose type II co will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-863446